Skip to content

Clinton Foundation secures price cuts for efavirenz, abacavir and rapid HIV tests

Roche to share know-how in making protease inhibitors with poorest countries

Mortality falls in HIV/HCV coinfected Spaniards after the introduction of effective HIV treatment

ICAAC: Switch from AZT or d4T to tenofovir may improve blood fat levels

ICAAC: Switching from Combivir to Truvada has benefits for treatment-experienced patients

High rate of resistance means azithromycin shouldn't be used to treat syphilis, warn doctors from San Francisco

Treatment interruption study stopped after excess number of AIDS events seen in people taking treatment breaks

Non-Hodgkin's lymphoma risk increased with prolonged high HIV viral load

Two integrase inhibitors now making progress in clinical trials